Epidemiology and genotypes analysis of human papillomavirus infection in Huizhou, China.

Zhun Shu, Wenli Zhao, Xuebing Zhan, Jiaqi Zeng, Jingyi Li
Author Information
  1. Zhun Shu: Department of Pathology, Huizhou First Hospital, Huizhou, Guangdong, China.
  2. Wenli Zhao: Department of Pathology, Huizhou First Hospital, Huizhou, Guangdong, China.
  3. Xuebing Zhan: Department of Pathology, Huizhou First Hospital, Huizhou, Guangdong, China.
  4. Jiaqi Zeng: Department of Dermatology, Zhuhai People's Hospital (Zhuhai Clinical Medical College of Jinan University), Zhuhai, Guangdong, China.
  5. Jingyi Li: Department of Dermatology, Huizhou First Hospital, Huizhou, Guangdong, China.

Abstract

Background: Human papillomavirus (HPV) is a main pathogenic factor for cervical carcinoma. The prevalence and genotypes distribution of HPV vary in different regions. Thus, our study aimed to investigate the epidemiology of HPV in Huizhou, China.
Methods: HPV tests were detected in 5,325 female outpatients, we focused on the overall HPV prevalence, genotypes distribution, and the correlation of HPV genotypes with cervical cytology.
Results: The overall HPV prevalence was 27.53%, HPV52, HPV58, HPV39, HPV16 and HPV51 were predominant genotypes with single infection rate of 70.80%. HPV infection rate showed a U-shaped age distribution, statistical differences were observed among 5 age groups (χ = 50.497, < 0.01), and the higher positive rate was aged under 30 (34.42%) and above 60 (34.74%). Among high-risk HPV (hrHPV) infections, 60.69% involved NILM, 0.99% HSIL. The degrees of cervical lesions in multiple hrHPV infections were worse than those in single infection ( < 0.01).
Conclusion: The HPV infection rate is high in Huizhou, Guangdong, single infection was predominant. HPV infection presented with a U-shaped age distribution. Multiple hrHPV infection was worrying since it may aggravate cervical lesions. Women should pay more attention to HPV detection and choose a more appropriate HPV vaccine according to local HPV type distribution.

Keywords

References

  1. BMC Infect Dis. 2014 Jul 12;14:388 [PMID: 25016305]
  2. Hum Vaccin Immunother. 2020 Jul 2;16(7):1645-1652 [PMID: 31809222]
  3. BMC Womens Health. 2019 Jul 8;19(1):90 [PMID: 31286939]
  4. Lab Invest. 2024 Apr;104(4):100328 [PMID: 38237737]
  5. J Cancer Epidemiol. 2011;2011:794861 [PMID: 21559068]
  6. J Med Virol. 2021 Aug;93(8):5103-5109 [PMID: 33847386]
  7. Lancet Glob Health. 2020 Feb;8(2):e180-e190 [PMID: 31862245]
  8. Emerg Microbes Infect. 2023 Dec;12(1):e2176009 [PMID: 36744409]
  9. Front Public Health. 2024 Mar 21;12:1332696 [PMID: 38590815]
  10. Virol J. 2022 Jan 15;19(1):13 [PMID: 35033141]
  11. BMC Public Health. 2017 Aug 3;18(1):95 [PMID: 28774274]
  12. Cancer Med. 2018 Oct;7(10):5217-5236 [PMID: 30589505]
  13. Chin J Cancer Res. 2020 Dec 31;32(6):720-728 [PMID: 33446995]
  14. Cancer Lett. 2021 Jan 28;497:243-254 [PMID: 33122098]
  15. BMC Infect Dis. 2023 Oct 7;23(1):667 [PMID: 37805467]
  16. Curr Probl Cancer. 2018 Sep;42(5):457-465 [PMID: 30064936]
  17. Cancer Lett. 2003 Aug 20;198(2):187-92 [PMID: 12957357]
  18. BMC Cancer. 2023 Dec 8;23(1):1211 [PMID: 38066444]
  19. BMC Infect Dis. 2017 Mar 23;17(1):226 [PMID: 28335818]
  20. Infect Agent Cancer. 2022 Apr 21;17(1):19 [PMID: 35449004]
  21. CA Cancer J Clin. 2021 May;71(3):209-249 [PMID: 33538338]
  22. Lancet Oncol. 2010 Nov;11(11):1048-56 [PMID: 20952254]
  23. Infect Dis Obstet Gynecol. 2013;2013:540850 [PMID: 24023507]
  24. Infect Dis Obstet Gynecol. 2006;2006 Suppl:40470 [PMID: 16967912]
  25. Front Immunol. 2023 Mar 13;14:1112750 [PMID: 36993948]
  26. Best Pract Res Clin Obstet Gynaecol. 2018 Feb;47:14-26 [PMID: 29037457]
  27. Can J Infect Dis Med Microbiol. 2016;2016:3076380 [PMID: 27366164]
  28. N Engl J Med. 2003 Feb 6;348(6):518-27 [PMID: 12571259]
  29. Virol J. 2022 Mar 4;19(1):37 [PMID: 35246180]
  30. BMC Infect Dis. 2023 Mar 13;23(1):152 [PMID: 36915050]
  31. Biomed Environ Sci. 2016 Oct;29(10):734-741 [PMID: 27927273]
  32. CA Cancer J Clin. 2018 Nov;68(6):394-424 [PMID: 30207593]
  33. Clin Microbiol Rev. 2003 Jan;16(1):1-17 [PMID: 12525422]

MeSH Term

Humans
Female
Papillomavirus Infections
China
Adult
Middle Aged
Genotype
Prevalence
Papillomaviridae
Aged
Young Adult
Uterine Cervical Neoplasms
Adolescent

Word Cloud

Created with Highcharts 10.0.0HPVinfectioncervicalgenotypesdistributionratepapillomavirusprevalenceHuizhouChinasingleagehrHPVlesions5overallpredominantU-shaped0013460infectionshumanBackground:HumanmainpathogenicfactorcarcinomavarydifferentregionsThusstudyaimedinvestigateepidemiologyMethods:testsdetected325femaleoutpatientsfocusedcorrelationcytologyResults:2753%HPV52HPV58HPV39HPV16HPV517080%showedstatisticaldifferencesobservedamonggroupsχ = 50497<higherpositiveaged3042%74%Amonghigh-risk69%involvedNILM99%HSILdegreesmultipleworse< 0Conclusion:highGuangdongpresentedMultipleworryingsincemayaggravateWomenpayattentiondetectionchooseappropriatevaccineaccordinglocaltypeEpidemiologyanalysiscancergenotype

Similar Articles

Cited By